NCT06220474View on ClinicalTrials.gov

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

NARecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

October 30, 2027

Study Completion Date

December 31, 2027

Conditions
Dry Eye SyndromesMeibomian Gland Dysfunction
Interventions
DEVICE

The Thermage FLX System

The Thermage FLX System is tested for its therapeutic efficacy and safety on treating refractory Meibomian Gland Dysfunction

DEVICE

Sham treatment

Sham treatment acts as a control to test the therapeutic efficacy and safety of The Thermage FLX System

Trial Locations (2)

Unknown

RECRUITING

Grantham Hospital, Hong Kong

RECRUITING

HKU Eye Centre, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER